Status:
ACTIVE_NOT_RECRUITING
Harnessing Telemedicine to Improve Alcohol Use Disorder Outcomes in Primary Care Patients
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Substance Use Disorders
Substance Use
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The purpose of this trial is to test new programs to see if they might help people manage their health and health behaviors related to alcohol use and well-being. The program sessions focus on getting...
Eligibility Criteria
Inclusion
- Current Diagnostic and Statistical Manual (DSM) -5 alcohol use disorder (AUD) based on alcohol symptom checklist
- An average of 3 or more drinking days per week for the past 30 days
- Have regular access to a device with video capabilities or a phone to use for study related calls
Exclusion
- Inability to speak or understand English
- Conditions that preclude informed consent or understanding of assessment or intervention content
- Past 90-day AUD psychotherapy treatment,
- At elevated risk for complicated alcohol withdrawal
- Past-year drug injection.
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT05410561
Start Date
November 1 2022
End Date
April 30 2026
Last Update
September 22 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Ann Arbor Health Care | Veterans Affairs
Ann Arbor, Michigan, United States, 48105
2
University of Michigan
Ann Arbor, Michigan, United States, 48109